Published on
May 11, 2026
- 18:07 GMT
Abinopharm Reports Clinical Success: Double-Blind Trial Validates AbinoNutra® NMN for Post-Exercise Muscle Recovery
New human clinical data demonstrates the safety and efficacy of AbinoNutra® NMN in reducing inflammation and balancing mitochondrial content in young athletes. SHELTON, CT, UNITED STATES, May 11, 2026 /EINPresswire.com/ -- Abinopharm, Inc., a pioneer in …
Distribution channels:
Beauty & Hair Care, Food & Beverage Industry
...
